相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bevacizumab in the treatment of ovarian cancer
Ernest S. Han et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Adventitial VEGF165 gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries
Carolin Deiner et al.
ATHEROSCLEROSIS (2006)
Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: Theory and clinical practice
Christopher G. Willett et al.
SEMINARS IN ONCOLOGY (2006)
Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin
N Cherradi et al.
MOLECULAR ENDOCRINOLOGY (2006)
Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways
ML Cho et al.
IMMUNOLOGY LETTERS (2006)
Heparanase induces vascular endothelial growth factor expression: Correlation with p38 phosphorylation levels and Src activation
A Zetser et al.
CANCER RESEARCH (2006)
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
S Garvin et al.
CANCER LETTERS (2006)
VEGF inhibitors in cancer therapy
AR Cardones et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: Basic science to clinical application
M Sund et al.
GASTROENTEROLOGY (2005)
Retinoic acid induces VEGF gene expression in human retinal pigment epithelial cells (ARPE-19)
JT Chen et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2005)
The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system
T Pufe et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2005)
A reassessment of vascular endothelial growth factor in central nervous system pathology
MJ Merrill et al.
JOURNAL OF NEUROSURGERY (2005)
Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor
S Kaga et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1
S Loeffler et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
VEGF polymorphisms and severity of atherosclerosis
WM Howell et al.
JOURNAL OF MEDICAL GENETICS (2005)
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complexthat regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
MJ Gray et al.
ONCOGENE (2005)
Direct intramyocardial plasmid vascular endothelial growth factor-A165-gene therapy in patients with stable severe angina pectoris -: A randomized double-blind placebo-controlled study:: The Euroinject One trial
J Kastrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Prolactin-induced expression of vascular endothelial growth factor via Egr-1
AS Goldhar et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
K Podar et al.
BLOOD (2005)
Transcriptional regulation of vascular endothelial growth factor in cancer
RMB Loureiro et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
DH Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Constitutive and inducible expression and regulation of vascular endothelial growth factor
KP Xie et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease - A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication
S Rajagopalan et al.
CIRCULATION (2003)
Vascular endothelial growth factor-D expression in human atherosclerotic lesions
J Rutanen et al.
CARDIOVASCULAR RESEARCH (2003)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade
JZ Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression
JE Ohm et al.
BLOOD (2003)
Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia -: Phase II results of the Kuopio Angiogenesis Trial (KAT)
M Hedman et al.
CIRCULATION (2003)
Vascular endothelial growth factor in ischemia for vascular angiogenesis
TD Henry et al.
CIRCULATION (2003)
Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling
B Govindarajan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
LH Wei et al.
ONCOGENE (2003)
Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1-and Sp3-dependent activation of two proximal GC-rich promoter elements
G Schäfer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inducible nitric oxide synthase expression in human colorectal cancer -: Correlation with tumor angiogenesis
F Cianchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-β1
PW Tsai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Signal transduction by vascular endothelial growth factor receptors
L Claesson-Welsh
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
DY Wei et al.
ONCOGENE (2003)
Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Spl) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes
P Brenneisen et al.
BIOCHEMICAL JOURNAL (2003)
Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis
JA Nagy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
M Mayerhofer et al.
BLOOD (2002)
Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers
L Yen et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Vascular and haematopoietic stem cells:: Novel targets for anti-angiogenesis therapy?
S Rafii et al.
NATURE REVIEWS CANCER (2002)
Molecular control of lymphangiogenesis
ME Baldwin et al.
BIOESSAYS (2002)
Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells
H Kawai et al.
ONCOGENE (2002)
The role of tumor lymphangiogenesis in metastatic spread
SA Stacker et al.
FASEB JOURNAL (2002)
Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma
H Igarashi et al.
CANCER (2002)
Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases -: Their implication in vascular endothelial growth factor gene transcription
J Milanini-Mongiat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Leptin and pubertal development
DR Mann et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2002)
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia
DW Losordo et al.
CIRCULATION (2002)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Smad4 transcriptional pathways and angiogenesis
I Schwarte-Waldhoff et al.
JOURNAL OF GASTROINTESTINAL CANCER (2002)
Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries
JH Bräsen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
D Lyden et al.
NATURE MEDICINE (2001)
A model for gene therapy of human hereditary lymphedema
MJ Karkkainen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: Role of MAP kinases
C Michiels et al.
IUBMB LIFE (2001)
Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways
JS Park et al.
ONCOGENE (2001)
Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A165 plasmid in patients with inoperable angina pectoris
C Sylvén et al.
CORONARY ARTERY DISEASE (2001)
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
H Miao et al.
NATURE CELL BIOLOGY (2001)
c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells
E Minet et al.
EXPERIMENTAL CELL RESEARCH (2001)
FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition
MJ Cross et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
I Zachary et al.
CARDIOVASCULAR RESEARCH (2001)
VEGF as a Mediator of tumor-associated immunodeficiency
JE Ohm et al.
IMMUNOLOGIC RESEARCH (2001)
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia
E Berra et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Oncogenes and tumor angiogenesis:: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner
O López-Ocejo et al.
ONCOGENE (2000)
Left ventricular electromechanical mapping to assess efficacy of phVEGP165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia
PR Vale et al.
CIRCULATION (2000)
Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability
G Pagès et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
I Schwarte-Waldhoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Expression of the vascular endothelial growth factor gene is inhibited by p73
B Salimath et al.
ONCOGENE (2000)
Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells
H Bamba et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Ultraviolet-A-induced transactivation of the vascular endothelial growth factor gene in HaCaT keratinocytes is conveyed by activator protein-2 transcription factor
J Gille et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes
M Funamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells
E Okajima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression
D D'Arcangelo et al.
CIRCULATION RESEARCH (2000)
Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty
M Laitinen et al.
HUMAN GENE THERAPY (2000)
Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion - Evidence for a dose-dependent effect
RC Hendel et al.
CIRCULATION (2000)
分享论文
